Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.
Status:
Terminated
Trial end date:
2020-04-30
Target enrollment:
Participant gender:
Summary
This was a double-blind, multi-centre, randomised, vehicle-controlled, within-subject phase
2a trial. The trial was designed to establish the efficacy and safety of delgocitinib cream
in the treatment of adult subjects with discoid lupus erythematosus (DLE).